LEEP: Loop Electrosurgical Excision Procedure

  • Sandra M. Sulik


Loop Electrosurgical Excision Procedure (LEEP) uses alternating electrical current to remove abnormal cervical tissue, which provides a specimen for pathological review. Historically, physicians have used high frequency current for lesion removal as early as the 1940s. The introduction of the large loop with an insulated cross bar in 1989 by Prendeville revolutionized the treatment of cervical dysplasia. Other methods, such as cryotherapy and laser vaporization evaporated tissue, did not allow for pathologic review. LEEP confers the advantage over cryotherapy and laser by providing tissue for histopathological review, thus allowing for prediction of recurrence of disease [1].


Cervical Dysplasia Transformation Zone High Frequency Current Endocervical Canal Cervical Incompetence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Prendiville W. Large loop excision of the transformation zone. Clin Obstet Gynecol 1995;38(3):622–639.PubMedCrossRefGoogle Scholar
  2. 2.
    Mayeaux EJ Jr, Harper MB. Loop electrosurgical excisional procedure. J Fam Pract1993; 36(2):214–219.PubMedGoogle Scholar
  3. 3.
    Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004 May 5;291(17):2100–2106.PubMedCrossRefGoogle Scholar
  4. 4.
    Samson SL, Bentley JR, Fahey TJ, Fahey TJ, McKay DJ, Gill GH. The effect of loop electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005;105(2):325–332.PubMedCrossRefGoogle Scholar
  5. 5.
    Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ., Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in-situ. Am J Obstet Gynecol 2007;197:340–345.PubMedCrossRefGoogle Scholar
  6. 6.
    Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J. Pre and postconization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006;103(2):631–636. Epub 2006 Jun 14.PubMedCrossRefGoogle Scholar

Additional Resource Article

  1. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ., Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346–355.PubMedCrossRefGoogle Scholar

Web Site

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Family MedicineSt. Joseph’s Family Medicine Residency, SUNY Upstate Medical CenterFayettevilleUSA

Personalised recommendations